CMPI - Checkmate Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $4.39. This is a potential upside of $4.39 (0%) from yesterday's end of day stock price of $0.

Checkmate Pharmaceuticals's activity chart (see below) currently has 1 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 106.5 days.

Most recent stock forecast was given by KAVERI POHLMAN from BTIG on 20-Apr-2022. First documented stock forecast 06-Oct-2021.

Best performing analysts who are covering CMPI - Checkmate Pharmaceuticals:

Geoff Meacham Kaveri Pohlman

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$9

2 years 7 months 2 days ago
(20-Apr-2022)

1/1 (100%)

$5.78 (179.50%)

20

Buy

$7

$-3.5 (-33.33%)

3 years 1 months 14 days ago
(08-Oct-2021)

1/1 (100%)

$2.99 (74.56%)

193

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CMPI (Checkmate Pharmaceuticals) average time for price targets to be met?

On average it took 106.5 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?

KAVERI POHLMAN

Which analyst has the most public recommendations on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham works at BAML and has 10 price targets and 8 ratings on CMPI

Which analyst is the currently most bullish on CMPI (Checkmate Pharmaceuticals)?

Kaveri Pohlman with highest potential upside - $0

Which analyst is the currently most reserved on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham with lowest potential downside - -$3.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?